Company’s 36-month beta value is 0.17.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ALLR is 3.96M, and currently, short sellers hold a 6.81% ratio of that floaft. The average trading volume of ALLR on January 15, 2025 was 1.13M shares.
ALLR) stock’s latest price update
Allarity Therapeutics Inc (NASDAQ: ALLR) has seen a rise in its stock price by 0.98 in relation to its previous close of 1.01. However, the company has experienced a 0.98% gain in its stock price over the last five trading sessions. accesswire.com reported 2025-01-15 that NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ:ALLR). Investors who purchased Allarity securities prior to May 17, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ALLR.
ALLR’s Market Performance
ALLR’s stock has risen by 0.98% in the past week, with a monthly drop of -0.98% and a quarterly drop of -28.68%. The volatility ratio for the week is 25.69% while the volatility levels for the last 30 days are 17.20% for Allarity Therapeutics Inc The simple moving average for the last 20 days is -2.68% for ALLR stock, with a simple moving average of -92.88% for the last 200 days.
ALLR Trading at -11.95% from the 50-Day Moving Average
After a stumble in the market that brought ALLR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.66% of loss for the given period.
Volatility was left at 17.20%, however, over the last 30 days, the volatility rate increased by 25.69%, as shares sank -0.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.50% lower at present.
During the last 5 trading sessions, ALLR rose by +0.50%, which changed the moving average for the period of 200-days by -99.44% in comparison to the 20-day moving average, which settled at $1.0478. In addition, Allarity Therapeutics Inc saw -12.83% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALLR
Current profitability levels for the company are sitting at:
- -221.46 for the present operating margin
- 0.89 for the gross margin
The net margin for Allarity Therapeutics Inc stands at -172.73. The total capital return value is set at -1.91. Equity return is now at value -391.95, with -109.68 for asset returns.
Based on Allarity Therapeutics Inc (ALLR), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -11.83. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -30.7.
Currently, EBITDA for the company is -12.08 million with net debt to EBITDA at 0.92. When we switch over and look at the enterprise to sales, we see a ratio of -112.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.75.
Conclusion
In a nutshell, Allarity Therapeutics Inc (ALLR) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
